Mar 17, 2008 - Astro-Med, Inc. (NASDAQ: ALOT) announced the availability of a new lightweight sleep screener for use in home sleep studies, to be sold under its Grass Technologies brand. The unit, called SleepTrek(R)3, was developed over a period of years in anticipation of approval for reimbursement by the Centers for Medicare and Medicaid Services (CMS) in Washington, D.C. On March 14, 2008, CMS announced its decision to provide for Medicare reimbursement of home sleep studies using devices such as Astro-Med's SleepTrek3...
...SleepTrek3 home sleep screener is the latest in the Grass Technologies family of sleep diagnostic products, which include full in-lab sleep screening systems, wireless sleep screeners, and type II sleep screeners. The Grass brand has developed PSG, EEG, and other neurophysiological monitoring systems since 1935, manufacturing and directly selling and supporting systems for use by hospitals and labs.... Astro-Med's Press Release -
Blog Archive
-
▼
2008
(56)
-
▼
April
(13)
- Arena : Phase 2b Clinical Trial of APD125 for the ...
- Medtronic : Agreement to Acquire Restore Medical
- Astro-Med : Home Sleep Screener as Medicare Issues...
- Southern Home Medical Equipment : Another Record M...
- Meda : exclusive world-wide commercialization righ...
- Neurogen : $30.6 Million Financing to Advance Clin...
- BTG : Positive Results from First Study Investigat...
- Itamar Medical : Watch-PAT to be included as an a...
- SleepEx : Agreement with the Atlanta School of Sle...
- SOMAXON PHARMACEUTICALS : NEW DRUG APPLICATION FOR...
- Graymark Healthcare : Letter of Intent to Acquire ...
- Jazz Pharmaceuticals, Inc. : Development Pipeline ...
- Philips : completion of Respironics acquisition
-
▼
April
(13)
Wednesday, April 23, 2008
Astro-Med : Home Sleep Screener as Medicare Issues New Guidelines for Home Sleep Study Reimbursement
Libellés :
Astro-Med,
Grass Technologies,
sleep diagnostic